COPD Antibody Success, Five Year Cervical Cancer Data, and Fat Cells Fighting Breast Cancer

Today we cover a new interleukin-thirty-three blocker that cuts COPD flare-ups, five-year survival data from the KEYNOTE-eight-twenty-six cervical cancer trial, real-world results for rimegepant in migraine, and a mouse study on semaglutide and aging. We also look at how healthy fat cells may protect against breast cancer, and a new genetic map of what drives prostate cancer. A quick rundown covers several more studies in AI drug discovery, genomics, and orthopedic surgery.